Executive Search Success Story: Building the Executive Leadership Foundation for a High-Growth In-Vitro Diagnostics Pioneer

How JRG Partners executed a confidential, multi-role executive search strategy that equipped an expanding in-vitro diagnostics (IVD) company with the specialized commercial, regulatory, and scientific leadership required to accelerate molecular product development, ensure global compliance, and scale market penetration.

The Challenge

A rapidly growing in-vitro diagnostics (IVD) company was facing a critical need to strengthen its executive leadership team. The organization had recently expanded its diagnostic testing portfolio, increased investments in molecular diagnostics and point-of-care technologies, and accelerated commercialization efforts across North America and international markets. While growth opportunities were significant, leadership identified several challenges that could impact long-term success:

• Increasing competition from established diagnostic manufacturers and emerging innovators
• Complex regulatory requirements across multiple markets
• Scaling commercial operations to support rapid growth
• Demand for stronger clinical, regulatory, and product leadership
• Supply chain and manufacturing challenges affecting product availability
• Succession concerns within several key executive positions
• Need for leaders capable of driving innovation while maintaining compliance and quality standards

The Board and CEO determined that multiple strategic leadership hires would be required to support the company’s next phase of growth. The confidential mandate included the recruitment of a Chief Executive Officer, Chief Commercial Officer, VP Regulatory Affairs, VP Quality Assurance, VP Manufacturing Operations, VP Research & Development, VP Clinical Affairs, and Director of Product Management. The company required an executive search partner with deep in-vitro diagnostics expertise and access to highly specialized leaders throughout the diagnostics industry.

Why They Chose JRG Partners

Deep Diagnostics & Life Sciences Expertise

JRG Partners maintains specialized executive search practices focused on diagnostics, medical devices, biotechnology, laboratory services, and healthcare technologies. This focus meant the search team understood the specific regulatory pathways, assay development complexities, and commercial dynamics of the IVD sector from day one.

Access to Passive Executive Talent

Many of the industry’s most accomplished executives are not actively pursuing new opportunities and are deeply embedded in scaling active product lines. Through extensive market relationships and industry research, JRG Partners identified leaders with proven success across diagnostic manufacturing, commercialization, regulatory affairs, and product innovation.

Confidential Search Execution

Several leadership searches involved succession planning and organizational restructuring initiatives. JRG Partners conducted each engagement with complete discretion, protecting day-to-day company operations and stakeholder confidence throughout the multi-hire deployment.

National and Global Reach

The search required access to executive talent across major life sciences hubs including Boston, San Diego, Minneapolis, Raleigh-Durham, San Francisco, Chicago, and international diagnostics markets, demanding a partner with a versatile geographic network.

Our Executive Search Strategy

Phase 1 — Leadership Assessment

Our consultants collaborated closely with the CEO, Board, and Human Resources leadership to evaluate organizational capabilities, leadership gaps, growth objectives, commercialization plans, regulatory and compliance requirements, product development priorities, succession risks, and future leadership competencies. The resulting executive profiles were designed to support both immediate business needs and long-term strategic growth.

Phase 2 — Market Mapping

JRG Partners conducted a comprehensive talent mapping initiative across in-vitro diagnostics manufacturers, molecular diagnostics companies, clinical laboratory organizations, point-of-care diagnostics providers, life sciences companies, emerging diagnostic technology innovators, and private equity-backed healthcare organizations. More than 450 executive profiles were assessed throughout North America and selected international markets.

Phase 3 — Executive Engagement

Using a targeted and research-driven methodology, our team engaged senior executives with demonstrated success in diagnostic product commercialization, regulatory approvals and compliance, clinical affairs leadership, product innovation and R&D, manufacturing scale-up, quality systems management, global market expansion, and strategic business growth. Only candidates with measurable achievements and direct industry experience advanced through the process.

Phase 4 — Assessment & Selection

Each finalist underwent an extensive evaluation focused on strategic leadership capabilities, industry expertise, regulatory and quality experience, team development skills, commercial acumen, innovation leadership, cultural alignment, and long-term retention potential.

Key Outcomes

• 450+ premium IVD, molecular assay, and point-of-care diagnostics executive profiles mapped across global medical technology markets.
• Assembled a comprehensive cross-functional leadership team spanning clinical affairs, R&D, commercial strategy, and operations within 12 months.
• Accelerated test development lifecycles and product-to-commercialization pipelines.
• Upgraded global regulatory and quality metrics to support smoother submissions with international health authorities.
• Streamlined multi-site manufacturing efficiency and optimized supply chains to stabilize domestic and international product availability.
• Quietly managed delicate corporate successions and structural changes, ensuring absolute operational continuity.